期刊文献+

卡马西平所致重症剥脱性皮炎型药疹附5例报告及文献复习 被引量:5

下载PDF
导出
摘要 目的探讨卡马西平所致重症剥脱性皮炎型药疹的临床资料、诊疗经过,复习相关文献以提高对本病的认识。方法分析5例卡马西平所致重症剥脱性皮炎型药疹的临床表现、诊疗和预后。结果 5例患者均在使用卡马西平1个月内出现症状,停用卡马西平,给予激素、预防感染等对症处理后症状消失。结论卡马西平所致重症剥脱性皮炎型药疹发生率低,一旦发生后果严重,注重预防是关键。
出处 《中国现代药物应用》 2016年第6期208-209,共2页 Chinese Journal of Modern Drug Application
基金 福建省自然科学基金资助项目(项目编号:2011J01164)
  • 相关文献

参考文献9

  • 1徐玮.卡马西平引起重症药疹8例临床分析.浙江大学,2007.
  • 2尹军花.卡马西平致严重药疹的原因分析及防治[J].中国误诊学杂志,2010,10(34):8552-8552. 被引量:5
  • 3P Brent F, Mcleod HL. Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations. Pharmacogenomics, 2008, 9(10):1543-1546.
  • 4谢建翔,张丽.重症药疹297例分析[J].中国医院药学杂志,2014,34(3):247-249. 被引量:22
  • 5曹育春,陈岚,李慎秋,刘继红,陈兴平.卡马西平引起药疹的特征分析[J].医药导报,2007,26(12):1512-1514. 被引量:4
  • 6Pei Chen, Juei-Jueng Lin, Chin-Song Lu, et al. Carbamazepine- Induced Toxic Effectsand HLA-B*1502 Screening in Taiwan. The new engl and journal of medicine, 2011,364(12):1126-1133.
  • 7Choong-Chor Chang, Chun-Lai Too. Association of HLA-B*1502 allele with carbamazepineinduced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population. International Journal of Dermatology, 2011, 50(2):221- 224.
  • 8Nahoko Kaniwa, Yoshiro Saito, Michiko Aihara, et al. HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia, 2010, 51(12):2461-2465.
  • 9Man CB, Kwan P, Baum L, et al. Association between HLA-B*1502 allele and antiepileptic druginducedcutaneous reactions in Han Chinese. Eoilensia. 2007.48(5):1015-1018.

二级参考文献23

  • 1曹兴梅.药源性剥脱性皮炎的发病机制及防治措施[J].中国现代药物应用,2007,1(4):67-68. 被引量:29
  • 2MISRA U K, KALITA J, RATHORE C. Phenytoin and carbamazepine cross reactivity: report of a case and review of literature[J]. Postgrad Med J, 2003,79(3) :703 -704.
  • 3郭勇 王侠生 孙清娟.卡马西平药疹10例临床分析.中国皮肤性病学杂志,1994,8(4):227-227.
  • 4LAM N S, YANG Y H. Clinical characteristics of childhood erythema multiforme, Steven-Johson syndrome and toxic epidermal necrolysis in the children of Chinese Taiwan[ J]. J Microbial lmmunol Infect, 2004, 37 ( 2 ) : 366 - 370.
  • 5Turk BD, Gunaydin, Errata I., et al. Adverse cutaneous drug reactions among hospitalized patients:five year surveillance[J]. Cutan Ocul Toxicol, 2013, 32(1): 41-45.
  • 6Sushma M, Noel MV, Ritika MC, et al. Cutaneous adverse drug reactions: a 9 year study from a Soulh Indian Hospital [J]. Pharmacoepidemiol Drug Saf, 2005, 14(8): 567- 570.
  • 7A1 Raaie F, Banodkar DD. Epidemiological study of cutaneous adverse drug reactions in Oman[J]. Oman Medical Journal, 2008, 23(1): 21 -27.
  • 8Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents A six year series from Chandigarh,lndia[J]. J Postgrad Med, 2001, 47 (2) : 95-99.
  • 9Ding WY, Lee CK, Choon SE. Cutaneous adverse drug reac tions seen in a tertiary hospital in Johor, Malaysia[J]. Interna tional Journal of Dermatology, 2010, 49(7) : 834- 841.
  • 10Hafner JW Jr, Belknap SM, Squillante MD, et al. Adverse drug events in emergency department patients[J]. Ann Emerg Med, 2(/02, 39(3): 258- 267.

共引文献28

同被引文献30

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部